BCS Bio Final

Opening Session

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY Opening Session

Opening Session

Dr. Felicia Knaul Director, Harvard Global Equity Initiative Associate Professor, Harvard Medical School Felicia Knaul, MA, PhD (Economics, Harvard University) is the newly- appointed director of the Harvard Global Equity Initiative and Associate Professor at the Harvard Medical School. She is also a Senior Associate with the Mexican Health Foundation, where she has collaborated with since 1994. As a result of her personal experience, she founded Cáncer de Mama: Tómatelo a Pecho (Breast Cancer: Take it to Heart) in 2007, a program that undertakes and promotes research, advocacy, awareness and early detection initiatives on breast cancer in Latin America. Her book on her life with breast cancer “Tómatelo a Pecho” was released in October.

Dr. Knaul has more than 100 publications and is a member of numerous organizations, including: Consultative Council of UNICEF in Mexico; Harvard-Mexico Foundation, Mexican Council on Competitiveness; and the High Level Early Childhood Development Secretariat at the Earth Institute of Columbia University. Dr. Knaul has held senior government posts at the Ministries of Education and Social Development in Mexico and at the Department of Planning of Colombia. She has worked for the WHO, World Bank, the Inter-American Development Bank and UNICEF. Dr. Knaul is Canadian, and resides in Boston and Mexico City. She and her husband, Dr. Julio Frenk, have two children, Hannah and Mariana Havivah.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

2 Opening Session

Dr. Jeffrey Flier Dean, Faculty of Medicine of the Harvard Medical School Jeffrey S. Flier was named dean of the Faculty of Medicine at Harvard University in 2007. An authority on the molecular causes of obesity and diabetes, Dean Flier is also the Carolyn Shields Walker professor of medicine at Harvard Medical School. Previously he served as the HMS faculty dean for academic programs and chief academic officer for Beth Israel Deaconess Medical Center.

Dean Flier received a BS from City College of New York in 1968 and an MD from Mount Sinai School of Medicine in 1972, graduating with the Elster Award for Highest Academic Standing. Following his residency training in internal medicine at Mount Sinai Hospital, he joined the National Institutes of Health. In 1978, he joined the Faculty of medicine at HMS and was named chief of the Diabetes Unit at Beth Israel Hospital until 1990, when he became chief of the Endocrine Division.

Dean Flier has authored more than 200 scholarly papers and reviews. He is a fellow of the Institute of Medicine of the National Academy of Sciences, the American Association for the Advancement of Science and the American Academy of Arts and Sciences.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

3 Opening Session

Dr. Margaret Chan Director-General, World Health Organization (WHO) Dr. Margaret Chan, from the People’s Republic of China, obtained her medical degree from the University of Western Ontario in Canada. She joined the Hong Kong Department of Health in 1978, where her career in public health began.

In 1994, Dr. Chan was appointed Director of Health of Hong Kong. In her nine-year tenure as director, she launched new services to prevent the spread of disease and promote better health. She also introduced new initiatives to improve communicable disease surveillance and response, enhance training for public health professionals, and establish better local and international collaboration. She effectively managed outbreaks of avian influenza and of severe acute respiratory syndrome.

In 2003, Dr. Chan joined WHO as Director of the Department for Protection of the Human Environment. In June 2005, she was appointed Director, Communicable Diseases Surveillance and Response as well as Representative of the Director- General for Pandemic Influenza. In September 2005, she was named Assistant Director-General for Communicable Diseases.

Dr. Chan was appointed to the post of Director-General on November 9, 2006. Her term will run through June 2012.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

4 Opening Session

Her Excellency, Madam Tobeka Madiba Zuma First Lady, The Republic of South Africa Vice Chairperson, Forum of African First Ladies Against Breast & Cervical Cancer Her Excellency Madame Tobeka Stacie Madiba-Zuma, First Lady KaMadiba of the Republic of South Africa, is a humanitarian activist and Vice Chairperson for Forum of African First Ladies Against Breast & Cervical Cancer. Madame Madiba-Zuma began her career in banking, development finance and cellular technology. As a leader in finance, she launched initiatives empowering young women and meeting community needs through various successful communication campaigns.

In her current role as Vice Chairperson for the Forum of African First Ladies Against Breast & Cervical Cancer she focuses her efforts in communication about cancer research and prevention. She has traveled extensively through Africa and globally as an ambassador for prevention and screening campaigns addressing cervical cancer and breast cancer.

As First Lady she has also focused her humanitarian efforts on the overall wellbeing of veterans and women, particularly the elderly, children and mothers. In addition to her work as a public spokesperson, she continues to assist orphaned children, particularly those living with HIV/AIDS, through meaningful public private partnerships.

Madame Madiba-Zuma is the mother of five children and lives in Durban.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

5 Opening Session

Dr. Lawrence N. Shulman Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute

Lawrence N. Shulman, M.D., is Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology at Dana-Farber Cancer Institute. He focuses his efforts on the clinical services for both adult and pediatric care at the Dana-Farber Cancer Institute (DFCI) and its partners, Brigham and Women’s Hospital, and Children’s Hospital. Dr. Shulman has served as one of the component leaders through the DFCI strategic planning initiative. He is Director of Network Development for Dana-Farber/Brigham and Women’s Cancer Center, and oversees DFCI ambulatory oncology units at several regional hospitals.

He is also physician leader for the development of clinical information systems for DFCI. He is a member of American Society of Clinical Oncology’s (ASCO) Quality of Care Committee and ASCO’s Electronic Health Record Workgroup. He is a member of the Commission on Cancer of the American College of Surgeons.

A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies. He is the national principal investigator on a North American Breast Intergroup Phase III Adjuvant trial, and is the Global Principal Investigator on a Phase III vaccine trial for patients with metastatic breast cancer.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

6 Opening Session

Her Royal Highness Princess Dina Mired Director-General, King Hussein Cancer Foundation; Honorary Chairperson, Jordan Breast Cancer Program, Hashemite Kingdom of Jordan As the mother of a cancer survivor, Princess Dina is passionate in her efforts to combat cancer. Since 2003, she has led the King Hussein Cancer Foundation (KHCF) as Director General. In this capacity, she founded and developed the Fundraising and Development Department of the Foundation, making it one of the best fundraising institutions in Jordan and the region. Today KHCF is the largest source of non-profit funds dedicated to combating cancer in Jordan.

Under her direct leadership, KHCF has succeeded in unifying and enlisting all segments of society in the fight against cancer. Princess Dina has also restructured and expanded KHCF’s Healthcare Program for cancer coverage, making it the only non-profit cancer coverage program in Jordan that also offers early detection services.

Princess Dina is the Honorary Chairperson of Jordan's National Breast Cancer Program. She is also the Honorary Member of the Mediterranean Task Force for Cancer Control in Italy and a LIVESTRONG Global Envoy for the Lance Armstrong Foundation.

KHCF is an independent non-governmental, not-for-profit institution to combat cancer in Jordan, and the Middle East region. KHCF is the legal umbrella organization responsible for the King Hussein Cancer Center, the Foundation’s medical arm.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

7 Opening Session

Dr. Drew Gilpin Faust President, Harvard University Drew Gilpin Faust took office as Harvard University’s 28th president on July 1, 2007. A historian of the U.S. Civil War and the American South, Dr. Faust is also the Lincoln Professor of History in the Faculty of Arts and Sciences. She previously served as founding dean of the Radcliffe Institute for Advanced Study (2001-2007).

Before coming to Radcliffe, Dr. Faust was the Annenberg Professor of History and director of the Women’s Studies Program at the University of Pennsylvania. She is the author of six books, including This Republic of Suffering: Death and the American Civil War (January, 2008), which was awarded the 2009 Bancroft Prize, the New-York Historical Society 2009 American History Book Prize, and recognized by The New York Times as one of the “Ten Best Books of 2008.”

Dr. Faust’s honors include awards in 1982 and 1996 for distinguished teaching at the University of Pennsylvania. She was elected to the American Academy of Arts and Sciences in 1994 and the American Philosophical Society in 2004. She received her bachelor’s degree from Bryn Mawr in 1968, magna cum laude with honors in history, and master’s (1971) and doctoral (1975) degrees in American civilization from the University of Pennsylvania.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

8 Opening Session

Dr. Paula A. Johnson Chief, Division of Women’s Health Executive Director, Connors Center for Women's Health and Gender Biology, Brigham and Women’s Hospital Paula A. Johnson, MD, MPH is the Executive Director of the Connors Center for Women’s Health and Gender Biology, and Chief of the Division of Women’s Health at Brigham and Women’s Hospital in Boston, MA. Dr. Johnson has built organizations which stand at the leading edge of hospital-based interdisciplinary healthcare delivery, discovery and disease prevention. Dr. Johnson started and grew the Connors Center for Women’s Health and Gender Biology. This nationally-recognized center includes an interdisciplinary health care practice model that solidifies the important connection between healthcare delivered to each patient and the health of entire communities.

She is an internationally recognized expert in defining disparities and improving the quality of cardiology care for women and minority populations.

Her vision, research, and ability to lead at the intersection of health care and public health has brought her key leadership roles in the local and national arena, including chair of the City of Boston’s Public Health Commission and member of the National Institutes of Health Advisory Committee on Research on Women’s Health.

Dr. Johnson is an Associate Professor of Medicine at Harvard Medical School. She is a graduate of Harvard Medical School, Harvard School of Public Health and Harvard and Radcliffe Colleges.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

9 Opening Session

Dr. Julio Frenk Dean, Harvard School of Public Health Julio Frenk, MD, MPH, Ph.D, is the dean of the Harvard School of Public Health. Dr. Frenk holds an MD from the National Autonomous University of Mexico, and an MPH, MA in Sociology and Ph.D. from the University of Michigan.

Dr. Frenk was founding Director- General of the National Institute of Public Health in Mexico, one of the developing world’s most respected and innovative centers of education and research in public health. He has held leadership positions in organizations such as the Mexican Health Foundation, World Health Organization, Bill & Melinda Gates Foundation, the Carso Health Institute in Mexico City, and the Institute for Health Metrics and Evaluation at the University of Washington.

As Minister of Health of Mexico from 2000 to 2006, Dr. Frenk reformed the nation’s health system and established a program of comprehensive national health insurance, known as Seguro Popular.

A member of the U.S. Institute of Medicine and the National Academy of Medicine of Mexico, he has served on numerous editorial boards and has published over 250 articles and books.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

10 Opening Keynote Speaker

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY Opening Keynote Speaker

Opening Keynote Speaker

Prof. Amartya Sen Nobel Laureate in Economics Thomas W. Lamont University Professor and Professor of Economics and Philosophy, Harvard University Chair, Harvard Global Equity Initiative Steering Committee Amartya Sen is Thomas W. Lamont University Professor, and Professor of Economics and Philosophy, at Harvard University and was until recently the Master of Trinity College, Cambridge. He has served as President of the Econometric Society, the Indian Economic Association, the American Economic Association and the International Economic Association. He was formerly Honorary President of OXFAM and is now its Honorary Advisor. Born in Santiniketan, India, Amartya Sen is an Indian citizen. He studied at Presidency College in Calcutta, India, and at Trinity College, Cambridge. He was Lamont University Professor at Harvard also earlier, from1988–1998, and previous to that he was the Drummond Professor of Political Economy at Oxford University, and a Fellow of All Souls College (he is now a Distinguished Fellow of All Souls). Prior to that he was Professor of Economics at Delhi University and at the London School of Economics.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

12 Opening Keynote Speaker

Choice, Welfare and Measurement (1982), Resources, Values and Development (1984), On Ethics and Economics (1987), The Standard of Living (1987), Inequality Reexamined (1992), Development as Freedom (1999), Rationality and Freedom (2002), The Argumentative Indian (2005), Identity and Violence: The Illusion of Destiny (2006) and The Idea of Justice (2009). His research has ranged over a number of fields in economics, philosophy, and decision theory, including social choice theory, welfare economics, theory of measurement, development economics, public health, gender studies, moral and political philosophy, and the economics of peace and war.

Amartya Sen has received honorary doctorates from major universities in North America, Europe, Asia and Africa. He is a Fellow of the British Academy, an Honorary Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal Society of Edinburgh, an Honorary Member of the Royal Irish Academy, a Foreign Honorary Member of the American Academy of Arts and Sciences, and a Member of the American Philosophical Society. Among the awards he has received are the “Bharat Ratna” (the highest honor awarded by the President of India); the Senator Giovanni Agnelli International Prize in Ethics; the Alan Shawn Feinstein World Hunger Award; the Edinburgh Medal; the Brazilian Ordem do Merito Cientifico (Grã-Cruz); the Presidency of the Italian Republic Medal; the Eisenhower Medal; Honorary Companion of Honour (UK); The George E. Marshall Award, and the Nobel Prize in Economics.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

All Speakers and Session Leaders

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY All Speakers and Session Leaders

All Speakers and Session Leaders

Dr. Hans-Olov Adami Professor and Chair, Department of Epidemiology, Harvard School of Public Health With a long background as a practicing surgeon with a focus on oncology, Dr. Adami has always conducted clinical and epidemiologic research in parallel. His clinical research includes randomized trials, prognostic studies, and studies of clinical issues using an observational study design. Over the years, however, his focus has been on cancer epidemiology, and he has worked on a large number of cancer sites and types. Currently, he is working predominantly on prostate cancer, (with research ranging from genetic association studies to randomized trials of radical surgical treatment, and prediction of outcome using molecular and genetic markers), malignant lymphomas, cervical cancer (with a focus on viral load as a possible determinant of progression from precursors to invasive cancer), and breast cancer. He is also involved in planning a large prospective cohort study in Sweden, and integrating this with other similar initiatives around the globe.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

15 All Speakers and Session Leaders

Dr. Eli Adashi Professor of Medical Science, Alpert Medical School, Brown University Senior Advisor, U.S. State Department Office for Global Women’s Issues The outgoing Dean of Medicine and Biological Sciences and the Frank L. Day Professor of Biology at Brown University, Dr. Adashi - a veteran practitioner of Women’s Health and an advocate for Reproductive Health, Freedom and Rights - is a member of the Institute of Medicine of the National Academy of Sciences, a member of the Association of American Physicians and a fellow of the American Association for the Advancement of Science. A member of the board of directors of Physicians for Human Rights, Dr. Adashi is also a member of the World Economic Forum’s Global Agenda Council on Population Growth, WHO’s IMPAC group, the Advisory Board of Maternova, the Advisory Board of the Peter and Patricia Gruber Foundation’s Women’s Rights Prize and the International Advisory Board of the Medical School for International Health of Ben-Gurion University of the Negev.

A long standing NIH funded investigator, Dr. Adashi is a former Research Career Development Awardee and a Donna Shalala appointee to the National Advisory Council of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Adashi authored or co-authored over 250 peer-reviewed publications, over 120 book chapters/ reviews and 13 books focusing on Women’s Health as well as on Ovarian Biology and Pathology.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

16 All Speakers and Session Leaders

Dr. Clement Adebamowo Associate Professor, Department of Epidemiology and Preventive Medicine, School of Medicine & Institute of Human Virology, University of Maryland, Baltimore Director, Office of Strategic Information and Research, Institute of Human Virology, Nigeria Dr. Clement Adebamowo is President of the Society of Oncology and Cancer Research of Nigeria, Director of the West African Bioethics Training Program, Convener of the Nigeria Malignancy Consortium and Associate Professor of Cancer Epidemiology at the University of Maryland, Baltimore. He is also Director of Research, Institute of Human Virology, Nigeria, where he oversees the development of research in treatment and prevention of HIV/AIDS, non-communicable diseases including cancers in Nigeria.

Dr. Adebamowo has extensive local and international research experience and has collaborated on several research projects including the International Haplotype Mapping Project, Epidemiology of Breast Cancer, and the African American Diabetes Mellitus study of the Center for Genomics and Global Health of the National Institutes of Health. He is the Nigerian Principal Investigator of the AIDS Malignancy Consortium Clinical Trials group and the International Breast Cancer Study Group. Dr. Adebamowo is the Chairman-elect of the International Affairs Committee of the American Society of Clinical Oncology; Member of the Expert Advisory Panel on Clinical Practice Guidelines and Research Methods and Ethics of the WHO and Editor-in-Chief of Bioethics Online Journal and Cancer in Africa Online Journal.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

17 All Speakers and Session Leaders

Dr. Samia Mohammed Al-Amoudi Associate Professor and Head of Sheikh Mohammed Hussen Al-Amoudi Scientific Chair for Breast Cancer, King Abdulaziz University, Jeddah, Saudi Arabia Global Advocate, Susan G. Komen for the Cure Dr. Samia Al-Amoudi is an Associate Professor at King Abdulaziz University (KAU) and a Consultant Obstetrician Gynecologist. She the Scientific Chair for Breast Cancer at KAU. Previously she has worked as Vice Dean of the College of Medicine and Allied Sciences and as a temporary advisor at the World Health Organization. In 2006, she was diagnosed with breast cancer and became the first Saudi to share her personal battle with the disease, breaking the silence to speak out about its impact.

Dr. Samia Al-Amoudi has several publications in medical journals about breast cancer and pregnancy and authored thirteen books. She has received a number of honors, including the first International Women of Courage Award by the US. Department of State, facilitating former First Lady Laura Bush’s visit to Jeddah, recognition by former President George Bush, and is a Global Advocate for Susan G. Komen for the Cure.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

18 All Speakers and Session Leaders

Mr. Paul Alofs President and CEO, The Princess Margaret Hospital Foundation Since joining The Princess Margaret Hospital Foundation as President and CEO in 2003, Paul Alofs has increased the organization’s revenues from $33 million a year when he joined to $70 million in 2008-09. The Foundation raises and stewards funds for Princess Margaret Hospital, one of the top 5 cancer research centers in the world.

Alofs’ career has been on a skyward trajectory since university. His resume includes Colgate-Palmolive Canada, The Marketing & Promotion Group, HMV Music Canada (annual revenue increased by 700% during his presidency), President of BMG Music Canada, The Walt Disney Company (overseeing 500 Disney Stores) and President, Strategic Business Units for the launch of MP3.com.

Paul has received the Outstanding Progress and Achievement Award from the Schulich School of Business and was named Innovative Retailer of the Year by The Retail Council of Canada. In 2005, Alofs was inducted into the Canadian Marketing Hall of Legends.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

19 All Speakers and Session Leaders

Dr. Benjamin O. Anderson Chair and Director, Breast Health Global Initiative Member, Fred Hutchinson Cancer Research Center Director, Breast Health Clinic, Seattle Cancer Care Alliance Professor of Surgery and Global Health Medicine, University of Washington, Seattle, Washington Dr. Benjamin O. Anderson, MD is Professor of Surgery and Global Health Medicine at the University of Washington in Seattle where he has devoted his clinical practice to the care of patients with breast cancer and breast health issues. Dr. Anderson’s clinical interests include oncoplastic surgery of the breast, the purpose of which is to improve oncologic and cosmetic outcome with complex breast cancer procedures. Dr. Anderson served as President of the American Society of Breast Disease from 2005 to 2007. He holds joint faculty positions in the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the University of Washington Department of Global Health. Dr. Anderson created and chairs the Breast Health Global Initiative, the purpose of which is to develop and implement resource- sensitive, culturally appropriate guidelines for breast cancer early detection, diagnosis and treatment in low- and middle- income countries (LMCs). As private sector advisor on the U.S. delegation to the 58th World Health Assembly held in Geneva, Dr. Anderson contributed to the first WHO Approved Resolution on Cancer Prevention and Control passed in 2005, the purpose of which is to reinforce comprehensive cancer policies and strategies for LMCs.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

20 All Speakers and Session Leaders

Prof. Rajendra A. Badwe Professor, Tata Memorial Centre

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

21 All Speakers and Session Leaders

Dr. Carmen Barroso Regional Director, International Planned Parenthood Federation/Western Hemisphere Region Carmen Barroso, MD became the Regional Director of International Planned Parenthood Federation/ Western Hemisphere Region in March 2003. A widely acknowledged leader in the field of sexual and reproductive health, Dr. Barroso served for twelve years as Director of Population and Reproductive Health of the John D. and Catherine T. MacArthur Foundation. Under her leadership, the foundation funded hundreds of non-governmental organizations in Africa, Asia, and Latin America and helped to bring the voices of Third World women to international policy fora. In academia, she has been a Hubert Humphrey Distinguished Professor at Macalester College and professor of sociology at the University of Sao Paulo. As a senior researcher of the Chagas Foundation, Dr. Barroso had a pioneering role in creating Brazil’s first and foremost women’s studies center. Dr. Barroso was a founding member of DAWN, a network of Third World women, and of the Funder’s Network on Population, Reproductive Health and Rights. She serves on the board of Hispanics in Philanthropy and Ibis Reproductive Health. She holds a PhD in social psychology from Columbia University and has been a Visiting Scholar at Cornell University.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

22 All Speakers and Session Leaders

Ms. Afsan Bhadelia Research Associate and Director of the Women and Health Program, Harvard Global Equity Initiative Afsan Bhadelia is a Research Associate, and Director of the Women and Health Program at the Harvard Global Equity Initiative. She earned a MS from the Friedman School of Nutrition Science and Policy, and a BS in Biology and International Relations from Tufts University. She holds a certificate in Humanitarian Studies from the Humanitarian Studies Initiative (HSI). She has previously worked as a Researcher at the Fletcher School of Law and Diplomacy, a Research Intern at the WHO Kobe Centre and an Albert Schweitzer Fellow with the International Rescue Committee. She has previously served as a Research Trainee with the NIH/Fogarty MIRT program and as a Fellow with the Tisch College of Citizenship and Public Service. Her research interests are focused on global health governance for strengthening health systems, multisectoral approaches to social determinants of health, and gender and health equity.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

23 All Speakers and Session Leaders

Dr. David E. Bloom Clarence James Gamble Professor of Economics and Demography and Chair, Department of Global Health and Population, Harvard School of Public Health David Bloom, MD, has worked extensively in the areas of development, health, and labor economics and in demography, and has published more than 250 articles, book chapters, and books. He has taught numerous courses on global health and population, labor and development economics, and statistics and econometrics, at both graduate and undergraduate levels. His current research focuses on the theoretical and empirical links between health, demography, and economic growth, and also on the value of vaccination.

Dr. Bloom serves as a Faculty Research Associate at the National Bureau of Economic Research, and is a member of the Board of Trustees of the American Foundation for AIDS Research. He has received various honors and awards for research and teaching, including a Sloan Fellowship, a Fulbright Fellowship, and a Visiting Scholar appointment at the Russell Sage Foundation. In April 2005 Dr. Bloom was elected Fellow of the American Academy of Arts and Sciences. He was also selected as a Paul G. Rogers Society Asador in January 2009.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

24 All Speakers and Session Leaders

Keynote Speaker: November 5th 2009

Ambassador Nancy G. Brinker Ambassador, Susan G. Komen for the Cure and the World Health Organization Ambassador Nancy G. Brinker is regarded as the leader of the global breast cancer movement. Her journey began with a simple promise to her dying sister, Susan G. Komen, that she would do everything possible to end the shame, pain, fear and hopelessness caused by this disease. In one generation, the organization that bears Susan’s name has changed the world.

Shortly after Susan’s death from breast cancer at the age of 36, Brinker founded Susan G. Komen for the Cure® in 1982. Brinker faced an immediate uphill battle: newspapers balked at printing the words “breast cancer,” no one talked openly about the disease, there were no 800-numbers, no internet and few, if any, support groups. Few treatment options existed for breast cancer patients and limited resources were committed to the disease. In a matter of years, Brinker broke the silence around breast cancer, and Komen for the Cure is now the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures.

Her creativity in raising awareness led to programs that at the time were revolutionary: in 1983, she founded the Susan G. Komen Race for the Cure®, which is now the world’s largest and most successful education and fundraising event for breast cancer. She also pioneered cause-related marketing, allowing millions

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

25 All Speakers and Session Leaders to participate in the fight against breast cancer through businesses that share Komen’s commitment to end the disease forever. Susan G. Komen for the Cure’s unwavering advocacy for breast cancer survivors led to new legislation and greater government research funding. To date, virtually every major advance in breast cancer research has been touched by hundreds of millions of dollars in Komen for the Cure funding.

Brinker’s determination to create a world without breast cancer is matched by her passion for enlisting every segment of society – from leaders to citizens – to participate in the battle. In 2009, President Barack Obama honored her with the Presidential Medal of Freedom, the nation’s highest civilian honor, for this work. The same year, she was named Goodwill Ambassador for Cancer Control for the United Nations’ World Health Organization, where she continues her mission to put cancer control at the top of the world health agenda.

Brinker was named one of TIME magazine’s “100 Most Influential People” in 2008. She served as U.S. Ambassador to the Republic of Hungary from 2001-2003 and most recently served as U.S. Chief of Protocol from 2007-2009 where she was responsible for overseeing all protocol matters for visiting heads of state and presidential travel abroad. In 2008, President George W. Bush appointed her to The Kennedy Center Board of Trustees.

She has received numerous accolades for her work, including the prestigious Mary Woodard Lasker Award for Public Service, the Trumpet Foundation’s President’s Award, the Independent Women’s Forum Barbara K. Olson Woman of Valor Award, the Champions of Excellence Award presented by the Centers for Disease Control, the Porter Prize presented by the University of Pittsburgh Graduate School of Public Health, the Forbes Trailblazer Award, Ladies Home Journal’s 100 Most Important Women of the 20th Century and Biography Magazine’s 25 Most Powerful Women in America.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

26 All Speakers and Session Leaders

Dr. Flavia Bustreo Director, Partnership for Maternal, Newborn and Child Health Dr. Flavia Bustreo is Director of The Partnership for Maternal, Newborn and Child Health, a Partnership Secretariat hosted by the WHO. She is a world-renowned physician with international health expertise and a long history with the WHO, United Nations, and the World Bank, where she served as Interim Deputy Director of the Child Survival Partnership and the United Nations. She is also a well-published scholar in the field of child survival.

As a Senior Public Health Specialist at the World Bank, Dr. Bustreo was responsible for the WHO-World Bank partnership for child health management. There, she was instrumental in the creation of the Partnership for Maternal, Newborn & Child Health. Dr Bustreo’s career in international health has focused on diseases affecting the poor and the disadvantaged, providing technical assistance to much of the developing world.

Dr. Bustreo started her career in Italy working with local non-governmental organizations to set up primary health care for refugees and assess the condition of children in post-war Iraq. Dr. Bustreo received a degree in medicine and a postgraduate qualification in rehabilitation medicine from Padua University, Italy, and later obtained an MSc in Communicable Disease Epidemiology from the London School of Hygiene and Tropical Medicine.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

27 All Speakers and Session Leaders

Dr. Maira Caleffi Breast Surgeon, Breast Center of Hospital Moinhos de Vento in Porto Alegre, RS, Brazil President, Instituições Filantrópicas de Apoio à Saúde da Mama (Brazilian Federation of Philanthropic Institutions for the Breast Health Support, or FEMAMA) After graduating with degrees in pharmacy and medicine, Dr. Caleffi completed her residency in gynecology and obstetrics in 1983. Afterwards, she specialized in breast care at the Imperial Cancer Research, Guy’s Hospital of London. At the University of London, she developed her doctoral thesis and then undertook postdoctoral studies in molecular biology in the field of genetics and breast cancer at Vanderbilt University in Nashville, Tennessee. Dr. Caleffi is a dedicated breast surgeon developing academic and hospital care work at the Breast Center of Hospital Moinhos de Vento in Porto Alegre, RS, Brazil, which has administrated since 2003.

Soon after returning to Brazil in 1993, she started a non-profit organization Instituto da Mama do Rio Grande do Sul (IMAMA) together with a group of health professionals and patients. IMAMA focuses on education, physical and emotional rehabilitation and social mobilization towards early breast cancer diagnosis. On July, 2006, she founded Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama (Brazilian Federation of Philanthropic Institutions for the Breast Health Support, or FEMAMA), another non-profit organization aimed at integrating groups and institutions working on breast health into a national network. FEMAMA’s mission is to influence the formulation of the national public health policies in order to ensure universality, integrality and equity in breast health care.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

28 All Speakers and Session Leaders

Dr. Corey Casper Director, Uganda Program on Cancer & Infectious Diseases, Fred Hutchinson Cancer Research Center Assistant Member, Vaccine Infectious Disease Institute, Fred Hutchinson Cancer Research Center Associate Professor of Medicine, Allergy & Infectious Disease, University of Washington Adjunct Associate Professor, Epidemiology and Global Health, University of Washington Dr. Casper, MD, MPH received his medical degree from Cornell University Medical College in 1997, followed by an internal medicine residency at UCSF. Moving onto the University of Washington, he completed a MPH in epidemiology in 2002 and his Infectious Disease fellowship training, joining the faculty in 2003. He currently is an Associate Professor of Medicine and an Adjunct Associate Professor of Epidemiology and Global Health at the University of Washington. He is an Assistant Member at the Fred Hutchinson Cancer Research Center in the Vaccine and Infectious Disease Institute. At the FHCRC, he directs the Uganda Program on Cancer and Infectious Diseases. This program in partnership with the Uganda Cancer Institute in Kampala, conducts research aimed at identifying how infections which cause cancer are acquired, defining strategies for the treatment and prevention of infection-related cancer, and training African and US health care providers to be the next generation of cancer researchers and care providers. Dr. Casper’s clinical areas of expertise include infections in the immunocompromised host, infection with the human herpes viruses including genital herpes (HSV-2), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and HHV-8, and the care of patients infected with the human immunodeficiency virus (HIV).

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

29 All Speakers and Session Leaders

Dr. Chan was appointed to the post of Director-General on November 9, 2006. Her term will run through June 2012.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

30 All Speakers and Session Leaders

Dr. Eduardo Cazap President, Latin American & Caribbean Society of Medical Oncology, Buenos Aires, Argentina President-Elect, International Union Against Cancer, Geneva, Switzerland Board of Directors, American Society of Clinical Oncology, Washington, United States Eduardo Cazap, MD, PhD, became the president of the Latin American & Caribbean Society of Medical Oncology in 2004 and has since become the Chairman Elect of the International Affairs Committee for the American Society of Clinical Oncology (ASCO) and President-Elect of the International Union Against Cancer (UICC).

After graduating in 1972 as a medical doctor from the University of Buenos Aires in his native city, Dr. Cazap worked as a medical oncologist at The Universidad del Salvador and completed fellowships at Strong Memorial Hospital, in Rochester, New York, the Lombardi Cancer Center at Georgetown University, Washington, D.C. and the American Cancer Society. Following his role as Principal Investigator of the Collaborative Cancer Research Treatment Program, he became a Professor of Clinical Oncology at the Universidad del Salvador and a Professor of Medical Oncology at the Universidad Católica Argentina.

As well as having published over 150 papers, Dr. Cazap has held many prominent positions in the medical arena, including: Instituto Dr. Estevez; European Society of Medical Oncology; the UICC; and the Argentine Association of Medical Oncology. Dr. Cazap founded the Charter of Paris against Cancer and was a member of various organizations, including: Developed Countries Task Force for the European Society for Medical Oncology; UICC World Congress Program Planning Executive Committee; and the American Cancer Society. BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

31 All Speakers and Session Leaders

Ms. Ilina Chaudhuri Fellow, Fundación Mexicana para la Salud (Mexican Health Foundation) and the Harvard Global Equity Initiative Ms. Ilina Chaudhuri, JD, MPH, graduated from Tufts University in 2003 with degrees in Biology, Biomedical Engineering, and Community Health. After graduating from Tufts, she worked at Brigham and Women’s Hospital, where she studied patient safety issues and medical error prevention. She completed a joint degree program at the University of Minnesota, where she earned her public health and law degrees. During this time, she held a graduate assistantship at the State Health Access Data Assistance Center in a Robert Wood Johnson Foundation office.

She has worked at the Harvard School of Public Health researching alternative systems to traditional medical malpractice claims, healthcare fraud and abuse, nursing home injury, and industry influence on academic medical centers. In summer 2007, Ms. Chaudhuri worked in Washington, DC at the O’Neill Institute for National and Global Health Law at Georgetown Law and the National Business Group on Health, for which she continues to consult.

Ms. Chaudhuri is currently an Upper Midwest Human Rights Fellow with the Fundación Mexicana para la Salud and the Harvard Global Equity Initiative. Her research interests include uninsurance, comparative health systems, and health equity.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

32 All Speakers and Session Leaders

Prof. Dov Chernichovsky Professor, Ben-Gurion University of the Negev Dov Chernichovsky (PhD Economics) is a professor of health economics and policy, Ben-Gurion University of the Negev, Israel. He is a Research Associate with the National Bureau of Economic Research in the US, and has been working and consulting for the World Bank. He heads the Health team at the Taub Center for the Study of Social Policy in Israel, and manages the Negev Health Forum for health promotion in the south of Israel. He serves on the boards of the Israeli Cancer Society, the Baxter Prize, and on the editorial boards of several journals.

Amongst membership in numerous commissions, Prof. Chernichovsky was a member Israeli State (Blue Ribbon/ Royal) “Netahnanyahu” Commission between 1988-1990, which outlined the reform proposal that led to the national health insurance legislation in Israel in 1995. In 2000-2002 he served on another similar commission that set further reform proposals to the Israeli system. He played key roles on behalf of the World Bank in health system reforms in Romania, Russia, and Mexico.

Prof. Chernichovsky’s research in Botswana, Brazil, India, Indonesia, and the US studying household behavior yielded pioneering economic studies in household investment in human resources, notably nutrition. Prof. Chernichovsky has become known for articulating “the favored son hypothesis” for investment in children’s schooling. Prof. Chernichovsky’s work has led to a formulation of Emerging Paradigm in health systems, a framework for studying and reforming these systems.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

33 All Speakers and Session Leaders

Ms. Alessandra Durstine Vice President for Regional Strategies, American Cancer Society, International Division Alessandra Durstine has twenty years of international experience working in public health, business development, media, and policy advocacy. She has worked both in the non-profit and for- profit arenas. In the non-profit sector she has worked at the United Nations Development Fund, the International Planned Parenthood Federation and the American Cancer Society in the areas of sustainability, corporate alliances and capacity building. Her for-profit experience includes eight years as vice president of International Marketing at ESPN, an international sports network. At the American Cancer Society, Alessandra oversees initiatives with a special focus on public/private sector partnerships, patient advocacy and institutional development, with a special focus on Latin America. She is a Venezuelan citizen who has lived in Latin America, Southeast Asia and Europe. She speaks Spanish, Portuguese and Italian. She has an MBA from the Wharton School of Business and a BA in International Relations from Tufts University.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

34 All Speakers and Session Leaders

Mr. Dai Ellis Executive Vice President, Access Programs at the Clinton Foundation HIV/AIDS Initiative Dai Ellis is the Executive Vice President of Access Programs at the Clinton Foundation HIV/AIDS Initiative, where he leads the Foundation’s work on improving the marketplace for HIV/AIDS and malaria drugs, diagnostics and other essential commodities. Mr. Ellis manages the Foundation’s relationships with both innovators and generic manufacturers and has negotiated agreements with companies across Asia, Europe, North America, and the Middle East.

Prior to his work at the Clinton Foundation, Mr. Ellis worked at McKinsey and Company serving clients in the pharmaceutical and biotechnology industries. He later joined the Center for Global Health and Economic Development at Columbia University under Dr. Jeffrey Sachs. His work at Columbia took him to Rwanda, where he worked as the advisor to the Director of the National AIDS Commission and helped to launch a national HIV/AIDS prevention and treatment program. While in Rwanda, he also co-founded Orphans of Rwanda, a nonprofit organization that provides university scholarships to orphans and other vulnerable youth. Mr. Ellis is a graduate of Yale Law School.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

35 All Speakers and Session Leaders

Dr. Paul Farmer Co-founder, Partners In Health Presley Professor of Social Medicine and the Chair of the Department of Global Health and Social Medicine, Harvard Medical School Chief of the Division of Global Health Equity, Brigham and Women’s Hospital Deputy Special Envoy to Haiti, United Nations Medical anthropologist and physician Paul Farmer, MD, PhD, has dedicated his life to improving health care for the world’s poorest people. He is a founding director of Partners In Health (PIH, 1987), an international non-profit organization that provides direct health care services and undertakes research and advocacy activities on behalf of those who are sick and living in poverty. Over the past twenty years, PIH has expanded operations to ten sites throughout Haiti, as well as nine other countries around the globe. The work has become a model for health care for poor communities worldwide: Dr. Farmer and his colleagues in the U.S. and abroad have pioneered novel community-based treatment strategies that successfully show that quality health care can be delivered in resource- poor settings. Dr. Farmer is also the Presley Professor of Social Medicine and the Chair of the Department of Global Health and Social Medicine at Harvard Medical School, Chief of the Division of Global Health Equity at Brigham and Women’s Hospital, and was recently appointed the United Nations Deputy Special Envoy to Haiti by former US President Bill Clinton. Dr. Farmer is a widely published author of numerous books and articles on health and human rights and social inequalities.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

36 All Speakers and Session Leaders

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

37 All Speakers and Session Leaders

Dr. Barbara Ferrer Executive Director, Boston Public Health Commission As the City’s Health Commissioner, Barbara Ferrer, Ph.D, MPH, Med, manages a $154 million budget and oversees 1,200 employees. In addition to operating public health programs, the Commission provides oversight of Boston Emergency Medical Services, several substance abuse treatment facilities, and the second largest homeless services program in New England. A high school principal in the Boston Public Schools, Dr. Ferrer returned to the Commission in 2007 after having previously served as the Deputy Director for six years. During that time she spearheaded a broad- based and comprehensive campaign to reduce racial and ethnic health disparities.

Dr. Ferrer has more than 25 years of experience working in healthcare. Prior to joining the Boston Public Health Commission, she spent five years at the Massachusetts Department of Public Health -- first as Director of Health Promotion and Chronic Disease Prevention and later as Director of the Division of Maternal and Child Health.

Dr. Ferrer received an MPH from Boston University, and was awarded a Pew Foundation doctoral fellowship to attend Brandeis University’s Heller School for Advanced Studies in Social Welfare. Dr. Ferrer also holds a MEd from the University of Massachusetts, Boston.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

38 All Speakers and Session Leaders

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

39 All Speakers and Session Leaders

As Minister of Health of Mexico from 2000 to 2006, Dr. Frenk reformed the nation’s health system and established a program of comprehensive national health insurance, known as Seguro Popular.

A member of the U.S. Institute of Medicine and the National Academy of Medicine of Mexico, he has served on numerous editorial boards and has published over 250 articles and books.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

40 All Speakers and Session Leaders

Dr. Mary Gospodarowicz Medical Director, Princess Margaret Hospital Cancer Program Regional Vice President, Cancer Care Ontario Professor and Chair, Department of Radiation Oncology, University of Toronto Chief, Radiation Medicine Program, Princess Margaret Hospital Mary Gospodarowicz, MD, FRCPC, FRCR (Hon.), FASTRO, received her degree in medicine from the University of Toronto and holds specialty certifications in internal medicine, medical oncology and radiation oncology. She is engaged in active clinical practice of radiation oncology treating patients with malignant lymphomas and genitourinary cancers. Her research interests include clinical trials evaluating the role of radiation therapy in lymphomas, prostate cancer, bladder cancer, and testis cancer. Currently, her interests are in developing and implementing image guided precision radiotherapy, late effects research, survivorship programs and research. She has a major interest in cancer staging and prognostic factor classification.

She is member of the Board of Directors of the International Union Against Cancer (UICC), an international non- governmental organization dedicated to the global control of cancer and also currently serves as Chair, UICC Membership Committee and Chair, UICC TNM (Classification of Malignant Tumors) Committee Task Force on Prognostic Factors. In the past 10 years, she has co-edited three books on Prognostic Factors in Cancer, the newest published for the 2006 UICC World Cancer Congress.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

41 All Speakers and Session Leaders

Dr. Julie Gralow Professor of Medical Oncology, University of Washington School of Medicine Dr. Julie Gralow is Professor, Medical Oncology, University of Washington (UW), and Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC). She is Director of Breast Medical Oncology at UW/Seattle Cancer Care Alliance, serves as Associate Program Head for the UW/FHCRC Consortium Breast Cancer Program, and is a member of the FHCRC Scientific Steering Committee.

Actively involved in clinical care, education, and research, she is PI on numerous local and national clinical trials related to breast cancer treatment, prevention, and survivorship. Her area of research specialization is the relationship between breast cancer and bone; she leads a 4,500 patient Phase III North American Breast Intergroup group trial investigating the role of bisphosphonates in preventing bone metastases.

Dr. Gralow is Vice-Chair of the Southwest Oncology Group’s Breast Cancer Committee and Co-Chair of the Breast Scientific Leadership Council of Coalition of Cancer Cooperative Groups. She is recent Chair of the American Society of Clinical Oncology (ASCO) Cancer Communications Committee, member of ASCO’s Nominating Committee, and recipient of an ASCO Statesman Award. She served as Co- Chair of an NCI State of the Science Conference, as Board Member of the American Society of Breast Disease, and directs the ACS/UW Medical Student Summer Research Fellowship Program.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

42 All Speakers and Session Leaders

Mr. Ramiro Guerrero Research Director, Harvard Global Equity Initiative Mr. Guerrero earned his degree in Economics from the Universidad de los Andes in Bogotá, Colombia, master’s degree in Environmental Economics from the University of Maryland at College Park, and master’s degree in Economic Policy from Université d´Auvergne, France. He took further doctoral level courses at Harvard University. Mr. Guerrero has worked in Colombia as Research Associate at Fedesarrollo, and Economics Editor at Semana. Between 2004 and 2007, he served as Deputy Minister of Social Protection in Colombia, where he was in charge of health system financing, information systems and planning.

Mr. Guerrero joined the Harvard Initiative for Global Health in 2007 as a Research Fellow, where he worked on health metrics and health system performance evaluation. He was also an active member of the Latin American Health Observatory. As of 2009, Mr. Guerrero has joined the Harvard Global Equity Initiative as Research Director.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

43 All Speakers and Session Leaders

Dr. Geeta Rao Gupta President, International Center for Research on Women Geeta Rao Gupta, PhD, is President of the International Center for Research on Women (ICRW), a leading global authority on women’s role in development, and passionate advocate for women’s empowerment and the protection and fulfillment of women’s human rights. Dr. Rao Gupta is an internationally renowned expert on women and AIDS, and is frequently consulted on issues related to HIV/AIDS. She has been recognized for her commitment to quality research and her dedication to educating policy makers and the public on the gender-related aspects of HIV/ AIDS.

Dr. Rao Gupta serves on several boards, including: Rural Development Institute; Nike Foundation; Global Health Corps; and the Moriah Fund. She is co-convener of the Social Drivers Working Group of aids2031, an international initiative commissioned by UNAIDS to chart a course for a global response to AIDS over the next twenty-five years; and has served as co-chair of the U.N. Millennium Project’s Task Force on promoting gender equality and empowering women. Dr. Rao Gupta has a PhD in Social Psychology from Bangalore University, a Master of Philosophy degree from the University of Delhi, and both a Master and Bachelor of Arts in Psychology from the University of Delhi.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

44 All Speakers and Session Leaders

Dr. Joe B. Harford Director, Office of International Affairs, National Cancer Institute, National Institutes of Health D Dr. Joe Harford serves as Director of the Office of International Affairs (OIA) of the National Cancer Institute with responsibility for a number of interactions involving the NCI and non-U.S. cancer research institutions. Dr. Harford chairs the Implementation Group of the Ireland-Northern Ireland-NCI Cancer Consortium and is the NCI liaison to the Middle East Cancer Consortium, the US-Japan Cooperative Cancer Research Program, the African Organization for Research and Training in Cancer, and the International Network for Cancer Treatment and Research. Dr. Harford has also represented the United States on the Governing Council of the WHO’s International Agency for Research on Cancer.

Dr. Harford has a BS in chemistry and a Ph.D in biochemistry. His research career focused on receptor-mediated processes and post-transcriptional regulation of genes involved in cellular iron metabolism. He has published over 100 scientific papers and served as the Series Editor for Modern Cell Biology. He edited the volume mRNA Metabolism and Post- transcriptional Gene Regulation for this series. Dr. Harford is a founding editor for Current Protocols in Cell Biology and for Short Protocols in Cell Biology.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

45 All Speakers and Session Leaders

Dr. Michelle D. Holmes Associate Professor of Medicine, Harvard Medical School Associate Professor of Epidemiology, Harvard School of Public Health Michelle Holmes, MD, DrPH, is an associate professor of medicine at Harvard Medical School and an associate professor in the department of Epidemiology at Harvard School of Public Health. Her research interests include lifestyle factors (diet, weight change, physical activity, and psychosocial factors, common medications) affecting quality of life and survival after a cancer diagnosis, as well as the association between diet and breast cancer risk. Other research interests include diet and lifestyle influences on endogenous levels of steroid hormones and insulin-like growth factors, and ethnic differences in obesity and other lifestyle factors affecting chronic disease risk. She co-edited a book on nutrition for cancer survivors published by the American Cancer Society. She has worked with the Nurses’ Health Study since 1997. Since 2007 she has helped to design collaborative longitudinal studies of non-communicable disease (obesity, diabetes, high blood pressure, heart disease, cancer) at five sites in sub-Saharan Africa.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

46 All Speakers and Session Leaders

Ms. Salma Jaouni Araj Director, Jordan Breast Cancer Program Salma Jaouni was entrusted in early 2007 with the establishment and management of the Jordan Breast Cancer Program. As the Director of this National program, Ms. Jaouni designed the strategy and established the team to develop and institutionalize early detection and universal screening of breast cancer. In the past two years, Jaouni and her team down staged breast cancer in Jordan through improving the quality, accessibility, and usability of screening services and increasing the awareness of women.

Prior to her work with the King Hussein Cancer Foundation, Ms. Jaouni worked with Booz Allen Hamilton as a senior consultant for the Middle East and Gulf regions on public policy projects. Ms. Jaouni has also held key positions with the World Bank and USAID consulting for governments in the Middle East on public health issues, poverty alleviation, employment strategies, and primary healthcare.

Ms. Jaouni holds a Master’s in Public Administration from Harvard Kennedy School, a Post Graduate Diploma in Health Systems Management from the School of Hygiene and Tropical Medicine at the University of London and a Bachelor of Sciences degree from the American University of Beirut in public health in addition to an excellent track record in leadership, negotiation, and communication skills.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

47 All Speakers and Session Leaders

She is an internationally recognized expert in defining disparities and improving the quality of cardiology care for women and minority populations.

Dr. Johnson is an Associate Professor of Medicine at Harvard Medical School. She is a graduate of Harvard Medical School, Harvard School of Public Health and Harvard and Radcliffe Colleges.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

48 All Speakers and Session Leaders

Ms. Ranjit Kaur President, Breast Cancer Welfare Association Malaysia Ms. Ranjit Kaur, a breast cancer survivor since 1998, and past president of Reach to Recovery International (2003-2007), is a member of the Board of Directors of the International Union against Cancer (UICC) since July 2006 and Executive Committee Member of Reach to Recovery International. She is the president of Breast Cancer Welfare Association, a reach to recovery program in Malaysia and president of Malaysian Breast Cancer Council, which is a national level coalition.

Ms. Kaur was conferred the 2004 Outstanding UICC Volunteer Award at the UICC World Conference for Cancer Organisations in Dublin in November 2004. Her article “Cancer - My Personal Account” was published in the Lancet. She was a committee member of Cancer Control Plans for Low- and Middle-Income Countries under the Institute of Medicine of the National Academies in the US. Ms. Kaur conducts training on psychosocial support for women diagnosed with breast cancer and their families, with an emphasis on socio-cultural aspects. She has presented papers and keynote addresses at national and international conferences. While the above positions are voluntary, Ms. Kaur has a full time job as Public Affairs Manager in a corporate company in Malaysia.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

49 All Speakers and Session Leaders

Dr. Nancy L. Keating Associate Professor of Medicine and Health Care Policy, Department of Health Care Policy, Harvard Medical School Associate Physician, Division of General Internal Medicine, Brigham and Women’s Hospital Dr. Keating is a health services researcher and a practicing general internist. Her research focuses on the quality of care delivered to patients with cancer. Much of her current research examines the influence of physicians, hospitals, and health care systems on care delivery for patients with cancer. Recently, Dr. Keating has examined cancer diagnosis and treatment in Puerto Rico and Costa Rica, and she has recently been funded by the American Cancer Society to examine the influence of Massachusetts health insurance reform on breast cancer screening and diagnosis. Dr. Keating received her MD degree from the University of Chicago, Pritzker School of Medicine, and her MPH degree from the Harvard School of Public Health. She currently serves as a member of the editorial board of the Journal of Clinical Oncology and she is a member of the National Comprehensive Cancer Center Senior Oncology Guideline Panel.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

50 All Speakers and Session Leaders

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

51 All Speakers and Session Leaders

Ms. Ksenia P. Koon Director of Breast Cancer Education and Outreach, Seattle Cancer Care Alliance Ksenia Koon, MS received her Bachelor of Science from the University of Washington and her Master of Science in Genetic Counseling from University of California, Berkeley, with a clinical focus on hereditary cancers syndromes. Ms. Koon began her career as a genetic counselor in Dr. Mary-Claire King’s laboratory at the University of Washington, working with families at hereditary risk for breast and ovarian cancer. She was a genetic counselor at the Fred Hutchinson Cancer Research Center from 2001 until 2005. Since June of 2005, Ms. Koon has been Director of Breast Cancer Education and Outreach at the Seattle Cancer Care Alliance, overseeing development and implementation of patient breast cancer education, physician education programs, and community and international breast cancer advocacy and outreach. Over the years, Ms. Koon has given numerous talks and has co-authored several publications on hereditary cancer and international advocacy. She also founded and facilitates the only support group in the Pacific Northwest for women at increased risk for breast and ovarian cancer. She is the Medical Advisory Committee Co-chair for Team Survivor Northwest and serves on the advisory board for two Hereditary Breast and Ovarian Cancer organizations, JACOB International and REACH Global.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

52 All Speakers and Session Leaders

Dr. Ana Langer Dr. Langer is the President and CEO of EngenderHealth. She is a physician with board certification in pediatrics and neonatology, as well as a reproductive health specialist and public health researcher. Dr. Langer is a distinguished worldwide leader in the application of research findings to influence policy and clinical norms for the improvement of reproductive health care services and the overall quality of women’s and family health.

For the past 20 years, Dr. Langer has been a leading advocate for advancing women’s health and quality reproductive health services in the Latin American and Caribbean region. For 11 years, she was the Population Council’s Regional Director for Latin America and the Caribbean, and she also served as Acting Director of the Council’s global Reproductive Health Program. In Mexico, Dr. Langer was a special advisor to the Minister of Health and directed the Division of Research on Women and Children’s Health for the National Institute of Public Health.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

53 All Speakers and Session Leaders

Dr. Constance D. Lehman Professor and Vice Chair of Radiology and Section Head of Breast Imaging, University of Washington Medical Center Director of Imaging, Seattle Cancer Care Alliance After graduating from Duke University, Dr. Lehman received her MD and PhD from Yale University. She received her residency and fellowship training at the University of Washington.

Dr. Lehman is chair of the breast committee for the American College of Radiology (ACR) Imaging Network, a member of the breast disease committee of the National Cancer Institute, and chair of the ACR committee for breast MRI accreditation.

She is a co-investigator for the National Breast Cancer Surveillance Consortium and has served as a principal investigator and a co- investigator on multi-institution National Cancer Institute clinical trials in breast MRI and ultrasound.

Dr. Lehman mentors residents, fellows and faculty in radiology on research projects, and is responsible for training residents and fellows in clinical breast imaging, including new methods of imaging and interventions. Her research is focused on new methods and applications of MRI in breast imaging as well as factors that influence the performance of mammography in early cancer detection.

Dr. Lehman has been a pioneer in the use of MRI for evaluating breast cancer and is recognized nationally and internationally for her excellence in clinical work, teaching, and research.

Dr. Lehman’s work has been featured on television, radio, and print media.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

54 All Speakers and Session Leaders

Dr. Eleni Linos Resident, Stanford University School of Medicine Eleni Linos completed her medical training at Cambridge and Oxford Universities in the United Kingdom. She subsequently worked on the link between lifestyle and breast cancer, with particular attention to identifying dietary risk factors during early life and adolescence. As part of her doctorate at the Harvard School of Public Health, Dr. Linos studied the impact of changing reproductive and demographic characteristics on breast cancer risk in China, and developed expertise in modeling cancer trends. She is now a resident at Stanford University School of Medicine department of Dermatology.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

55 All Speakers and Session Leaders

Lizbeth López-Carrillo Epidemiologist, Instituto Nacional de Salud Publica (Mexico National Institute of Public Health) Dr. Lopez-Carrillo, DrPh, is a chemist- epidemiologist, having earned her doctoral degree from Yale University. She has worked for the Mexico Ministry of Health as the Head of the Department of Chronic Disease Research, Director of the Division of Research on Development and Health, and currently she is a Senior Researcher at the National Institute of Public Health of Mexico. She has designed and conducted several population-based epidemiologic studies mainly focused on the evaluation of dietary habits, exposure to environmental pollutants and their role in breast and gastric cancer. She is currently performing a perinatal environmental cohort study in a poor Mexican population. She served as Councilor of the International Society for Environmental Epidemiology Latin- American Chapter, President of the Health area at the National System of Researchers among other academic appointments. She works to strengthen regional collaborative research, find opportunities for capacity building and foster decision making in regards to common environmental preventable problems.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

56 All Speakers and Session Leaders

Dr. Richard R. Love Scientific Director, International Breast Cancer Research Foundation Dr. Love is an international breast cancer public health oncologist and social entrepreneur. For the last twenty years the focus of his work has been on understanding and intervening in the hormonal biology of breast cancer. He reported the first evidence in humans for selective estrogen receptor modulators, hormones that act both as estrogens and anti-estrogens, and conducted a clinical trial which established combined hormonal therapy with surgical oophorectomy and tamoxifen as an adjuvant standard of care for premenopausal women.

Currently he is leading two phase III clinical trials of this therapy in Vietnamese and Philippino women investigating an hypothesis about timing of surgery and benefits. In Bangladesh he is developing a population-targeting program to decrease mortality from breast cancer, with community, cultural, primary health worker, specialty care, basic, translational and clinical research projects. Dr. Love believes that the central issues is addressing breast cancer in low and middle income countries are in human rights and the inapplicability of any “standard” treatments across populations because of tumor, host, cultural and health systems differences. These issues mandate “search and research” approaches to improving breast cancer outcomes in different population country settings.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

57 All Speakers and Session Leaders

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

58 All Speakers and Session Leaders

Dr. Alejandro Mohar Betancourt General Director of Instituto Nacional de Cancerología, México (National Cancer Institute of Mexico) Alejandro Mohar Betancourt, MD, ScD, is the current director of the National Cancer Institute of Mexico (INCAN), the leading institution and governing body for cancer control in Mexico. He was recently renominated for another five-year term as director of the organization. In this role, Dr. Mohar manages INCAN’s involvement in cancer policy, treatment, education, and research in Mexico. Previously, he served as the Director of Research at INCAN, as a visiting professor at Stanford University, and as a research associate at Harvard University. He started his career working on HIV/AIDS research at Harvard. He brings a public health and medical perspective to the burden of cancer in Latin America and to the interventions that can prevent and treat the disease.

Dr. Mohar has served as an editor in chief or associate editor of several prestigious medical journals. His many published works have been featured in a wide variety of medical journals, books, and national and international congresses. He has been appointed to the board of trustees of the Universidad Autonoma de Mexico, the largest university in Mexico. He is a member of the National Academy of Medicine in Mexico and the Mexican Academy of Sciences.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

59 All Speakers and Session Leaders

Dr. Steven Narod Senior Scientist, Women’s College Research Institute and University of Toronto Dr. Narod conducts longitudinal studies of women from families with and without genetic mutations related to breast cancer. He is currently focused on translating our emerging knowledge about hereditary cancer into more effective strategies for the prevention and management of breast and ovarian cancer. He is also interested in delineating the gene/ environment interactions that underlie hereditary breast cancer. This work may eventually be used to identify potential modifiers of cancer risk in high-risk groups. He is currently principal investigator on a number of studies looking at risk factors associated with hereditary breast and ovarian cancer, investigating the role of BRCA2 mutations in ovarian cancer, and investigating the contributions of CHK2 gene mutations to breast cancer risk. He also participates as a co-investigator on a wide-range of hereditary cancer studies conducted by his students and international colleagues.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

60 All Speakers and Session Leaders

Dr. Gustavo Nigenda López Director, Innovation Services and Health Systems at the Centro de Investigación en Sistemas de Salud, Instituto Nacional de Salud Pública (Center for Health Systems Research, National Institute of Public Health in Mexico) Dr. Nigenda earned his PhD in Health Policy from the London School of Economics and Political Science. Since 1980 he has worked with research groups in the field of public health. He is currently Director of Innovation Services and Health Systems and Coordinator of the Doctoral Program on Health Systems at the Mexican National Institute of Public Health. He is also a member of the research group and consultant for “Cáncer de Mama: Tómatelo a Pecho,” an initiative with the goal of reducing breast cancer mortality in Latin America through early detection and effective treatment. He has published extensively on various topics including human resources for health, health policy, social health protection and health system reforms in Mexico.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

61 All Speakers and Session Leaders

Dr. Marina Alois Njelekela Chairperson, Medical Women Association of Tanzania Marina Njelekela, MD, PhD, is the Chairperson of Medical Women Association of Tanzania (MEWATA), Lecturer, and current Chair of the D e p a r t m e n t o f P h y s i o l o g y a t Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Dr. Njelekela has been actively involved in Breast Cancer Screening and Awareness Campaigns for women in seven regions in Tanzania. MEWATA has screened 63,895 women and found 2,978 with various breast problems, including breast cancer. Though breast cancer is a public health problem in Tanzania, it is not highly prioritized and very little information is available on breast morbidity and mortality. In recognition of this, MEWATA screens and provides health education to raise community awareness to recognize signs and symptoms of breast and cervical cancers and the importance of seeking early medical care. Dr. Njelekela also has significant experience in research and training related to Cardiovascular and Pulmonary Diseases (CVPD). She has been involved in various studies to determine the prevalence rates and intervention studies for risk factors for CVPD and diabetes in Tanzania. Dr. Njelekela is widely published in the peer reviewed literature.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

62 All Speakers and Session Leaders

Dr. Larry Norton Deputy Physician-in-Chief for Breast Cancer Programs, Memorial Sloan- Kettering Cancer Center Larry Norton, M.D is Deputy Physician-in-Chief and Director of Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center. He is Scientific Director of The Breast Cancer Research Foundation and has served as chairman of its Medical Advisory Board since its inception in 1993. A Presidential Appointee to the National Cancer Advisory Board of the NCI (1998-2004), he is the first incumbent of the Norna S. Sarofim Chair in Clinical Oncology at MSKCC and recipient of the American Society of Clinical Oncology’s 2004 David A. Karnofsky Memorial Award.

After receiving his MD from Columbia University, he trained in Internal Medicine at the Albert Einstein College of Medicine. He then served as a Clinical Associate and Investigator at the NCI prior to joining the faculty of the Mount Sinai Medical Center. He is currently Professor of Medicine, Weill Medical College of Cornell University.

Dr. Norton has served on or chaired numerous committees of governmental and professional organizations such as NCI and Institute of Medicine. Dr. Norton is on the editorial board of several medical publications, and is an active clinical and laboratory investigator. He is the co-author of the Norton- Simon Model, which has broadly influenced cancer treatment and research for over twenty-five years.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

63 All Speakers and Session Leaders

Princess Nikky Onyeri Founder and Executive Director, Princess Nikky Breast Cancer Foundation Princess Nikky Onyeri is the foremost breast and cervical cancer activist in Africa. After earning degrees in economics and communications, she founded a Nigerian NGO, Princess Nikky Breast Cancer Foundation. Her vision is a world without cancer, especially in Africa and developing countries.

Princess Nikky has raised the profile of cancer in Nigeria and around Africa. Notable successes include: the introduction of World Cancer Day in the health calendar of some African countries, establishment of National Cancer Plans in Africa, Forum of African First Ladies Against Breast and Cervical Cancer, African Parliamentarians and Health Minister’s Against Cancer, Stop Cervical Cancer in Africa Conference and Annual Africa Breast Cancer Conference, and Reach for Recovery International in Nigeria.

A world travelled motivational speaker, Princess Nikky works closely with such bodies and organizations as the International Union Against Cancer, WHO, International Atomic Energy Agency, International Agency on Cancer Research, International Agency for Research on Cancer, Bill and Melinda Gates Foundation, international health non-profit PATH, GlaxoSmithKline, Merck, Novartis Oncology, Qiagen, National Breast Cancer Coalition Fund, and Lance Armstrong Foundation.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

64 All Speakers and Session Leaders

Prof. Peter Piot Director, Institute for Global Health, Imperial College Peter Piot, MD, PhD is Professor of Global Health and Director of the Institute for Global Health at Imperial College in London. He was the founding Executive Director of UNAIDS and Under-Secretary of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of WHO.

Dr. Piot co-discovered the Ebola virus in Zaire in 1976, and led research on HIV/AIDS, women’s health, and public health in Africa. He was a professor at several universities around the globe, was a Senior Fellow at the University of Washington, a Scholar in Residence at the Ford Foundation, and a Senior Fellow at the Bill and Melinda Gates Foundation. He holds the chair 2009/2010 “Science against poverty” at the College de France in Paris, and is a visiting professor at the London School of Economics.

He is a member of the Institute of Medicine of the US National Academy of Sciences, and of the Royal Academy of Medicine of his native Belgium, and a fellow of the Royal College of Physicians. He is the President of the King Baudouin Foundation, was knighted as a baron in 1995, and published over 500 scientific articles and 16 books.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

65 All Speakers and Session Leaders

Dr. Peggy Porter Full Member, Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center Co-Head, Women’s Cancer Research Program, Fred Hutchinson/University of Washington Cancer Consortium Professor, Department of Pathology, University of Washington Dr. Peggy Porter, member of the Divisions of Human Biology and Public Health Sciences at Fred Hutchinson Cancer Research Center, is co-head of the Women's Cancer Research Program, a dynamic group of researchers and clinicians dedicated to reducing the incidence and subsequent mortality of breast cancer. Her lab focuses on identifying the molecular events associated with initiation and progression of breast cancer. In collaboration with epidemiologists and basic scientists, the Porter lab identified the loss of cell cycle inhibitor p27 as an important indicator of poor prognosis in breast cancer.

With collaborators in Atlanta Dr. Porter found that specific abnormalities in expression of cell cycle regulatory proteins might contribute to the aggressive phenotype seen at a high frequency in black women. She collaborated in the Shanghai, PRC study that found no mortality reduction associated with breast self exam and currently collaborates on a study in Bryansk, Russia to determine the risk of breast cancer associated with radiation exposure from the Chernobyl incident. She obtained her medical degree in 1987 from the University of New Mexico and completed her residency in Pathology at the University of Washington where she was a recipient of the American Cancer Society Clinical Oncology Fellowship.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

66 All Speakers and Session Leaders

Dr. María del Rocío Sáenz Madrigal Coordinator of Health Policies at the Health and Work Program, Central America’s National University Professor, School of Public Health, University of Costa Rica’s School Dr. Sáenz is an international expert in public health, disaster management, and health sector reform in Latin America. She earned her medical degree from La Salle University in Mexico and an MPH from the University of Costa Rica. She is Coordinator of Health Policies at National University’s Health and Work Program for Central America. She is a professor at the University of Costa Rica’s School of Public Health and Senior Adviser of the Health Observatory for Latin America and the Caribbean.

From 2002 until 2006, she was Minister of Health in Costa Rica, and from 2004 to 2006 she coordinated the Costa Rican Ministry of the Social Sector. During this time, she was a member of the Central America Council of Health Ministers and Minister of Social Integration for Costa Rica at the Central America Council of Social Integration.

Dr. Saenz is currently a member of several organizations, including: College of Physicians and Surgeons of Costa Rica, Public Health Association of Costa Rica, and the Pan American Health Organization’s initiative on safe hospitals. She is president of a foundation that promotes access to scientific information regarding disasters in Latin America and the Caribbean.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

67 All Speakers and Session Leaders

Dr. Rengaswamy Sankaranarayanan Head, Section of Early Detection and Prevention Head, Screening Group, International Agency for Research on Cancer, World Health Organization, Lyon, France R. Sankaranarayanan, MD, is currently Head of the Section of Early Detection and Prevention and Head of the Screening Group at the International Agency for Research on Cancer of the World Health Organization in Lyon, France.

He has a major interest in early detection of cancer and cancer control, particularly in less developed countries. He has more than 150 publications in international journals of repute and has authored widely acclaimed manuals on early detection of cervical cancer, which have been translated into several languages including Chinese, French, Hindi, Portuguese, Spanish, and Turkish, among others.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

68 All Speakers and Session Leaders

Dr. Mahmoud M. Sarhan CEO and Director, General King Hussein Cancer Center Executive Chairman, Jordan Breast Cancer Program Dr. Mahmoud Sarhan, MD, MMM, CPE, is the CEO/Director General of the King Hussein Cancer Center (KHCC) since March 2006. Dr. Sarhan has led a number of major projects within KHCC to ensure the provision of the state of the art and quality medical services. Under his leadership, KHCC was accredited and reaccredited as a general hospital by the Joint Commission International, and also received the only disease specific accreditation outside North America in oncology.

Dr. Sarhan joined KHCC in 2002 as the Chairman of the Pediatrics Department, Director of Bone Marrow and Stem Cell Transplantation Program, and the Director of the Hematology Oncology Fellowship Program. He is the chairman of the board of the Jordan Breast Cancer Program and the Chairman of the National Palliative Care Committee. He has just been awarded by WHO the Kuwait Prize for Cancer Control in appreciation of his work in this field.

Prior to joining KHCC, Dr. Sarhan was the Director for the Pediatric Bone Marrow Transplant Program at King Faisal Specialist Hospital in Saudi Arabia, after which he joined Duke University as a Professor of Pediatrics in the Bone Marrow and Stem Cell Transplantation Program.

Dr. Sarhan earned his MD from the University of Jordan. He is a renowned expert and researcher in the field of stem cell and bone marrow transplantation, the author of over 90 peer-reviewed articles, and a member in the American College of Physician Executives.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

69 All Speakers and Session Leaders

Dr. John Reese Seffrin CEO, American Cancer Society John Seffrin is the chief executive officer of the world’s largest voluntary health organization devoted to fighting cancer – the American Cancer Society. During his 17-year tenure, he has transformed the Society into one of the world’s most progressive public health organizations, with more than a billion dollars in resources to help people everywhere stay well and get well, to find cures, and to fight back against cancer.

Dr. Seffrin has been on the frontlines of the war against cancer for many years. He served as president of the International Union Against Cancer from 2002-2006 and chaired the board of Independent Sector from 2002-2005. He is a charter member of the C-Change (formerly known as the National Dialogue on Cancer) Steering Committee, and led the creation of the National Center for Tobacco-Free Kids, serving as its initial board chair. Dr. Seffrin is a preeminent leader of the international tobacco control movement, having served on numerous committees on the topic, and is an internationally esteemed speaker and a prolific author. Ball State University, Purdue University, Thomas Jefferson University, and Indiana University have awarded him honorary doctorates in recognition of his more than three decades of leadership in the worldwide fight against cancer.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

70 All Speakers and Session Leaders

Amartya Sen’s books have been translated into more than thirty languages, and include Choice of Techniques (1960), Collective Choice and Social Welfare (1970), On Economic Inequality (1973, 1997), Poverty and Famines (1981), Choice, Welfare and Measurement (1982), Resources, Values and Development (1984), On Ethics and Economics

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

71 All Speakers and Session Leaders

(1987), The Standard of Living (1987), Inequality Reexamined (1992), Development as Freedom (1999), Rationality and Freedom (2002), The Argumentative Indian (2005), Identity and Violence: The Illusion of Destiny (2006) and The Idea of Justice (2009). His research has ranged over a number of fields in economics, philosophy, and decision theory, including social choice theory, welfare economics, theory of measurement, development economics, public health, gender studies, moral and political philosophy, and the economics of peace and war.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

72 All Speakers and Session Leaders

Dr. Mohamed Shaalan Chairman, Breast Cancer Foundation of Egypt Associate Professor of Surgical Oncology, National Cancer Institute, Cairo Mohamed Shaalan, MD, is spreading information and awareness, improving early detection and other services, and helping women to confront the illness from an informed position, so they may consider the best options for their care.

Dr. Shaalan is changing the perceptions about breast cancer to eliminate the barriers that impede breast cancer detection, education and care. His aim is to create and institutionalize a culture that equips women with knowledge and empowers patients with confidence and self-respect. He is correcting the myths, misconceptions, taboos, and stigmas surrounding breast cancer, commonly known in Egypt as the “bad disease.” A master organizer, he is bringing citizenship to patients with breast cancer and face systematic discrimination as a result of ignorance on the part of society, doctors, nurses, and the government. He is creating institutions to document the problems and provide information, counsel, subsidized screenings, and post-operative care. In addition, he is creating an advocacy committee whose members are patients, doctors, celebrities, and decision makers who will lobby for the creation of a governmental body to secure quality medical care. He has been an Ashoka fellow for the 4 years.

AWARDED THE WHO AWARD FOR ANTICANCER ACTIVITIES Dr. Shaalan arranged the first ever RACE FOR THE CURE around the Pyramids 24 October 2009 with KOMEN. Arranged the 15 international breast cancer symposium with university of Florida in Cairo 25 October. Member of the health committee in Egypt ruling party, co-director of the NCI of Egypt.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

73 All Speakers and Session Leaders

Dr. Rola Shaheen Chief of Radiology and Director of Women’s Imaging, Harrington Memorial Hospital Dr. Rola Shaheen is Chief of Radiology and the Director of Women’s Imaging at Harrington Memorial Hospital in Southbridge MA, a staff radiologist at Beth Israel Deaconess Medical Center (BIDMC) and an instructor in radiology at Harvard Medical School. She graduated from the Faculty of Medicine of Jordan University-Amman in 1996 and completed an internship and radiology residency at University of Toronto in 2007. She completed her women’s imaging fellowship at BIDMC. The majority of her practice is in women’s imaging with a focus on breast imaging, followed by obstetric and gynecology ultrasounds. She has a particular interest in fetal MRI.

Dr. Shaheen’s research interests include breast MRI and international public health projects focusing on promoting screening mammography in the Gaza Strip and the Middle East. She has given talks in gynecological ultrasound at national conferences such as the Radiological Society of North America (RSNA) and Society of Radiologists in Ultrasound (SRU). She is a Cum Laude award winner for an educational exhibit at RSNA. Dr. Shaheen is devoted to teaching medical students and radiology residents at Harvard Medical School. She has been an invited faculty speaker to national and international universities and is a longtime advocate for screening mammography and a believer in multidisciplinary clinical approach for management of breast cancer under one roof.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

74 All Speakers and Session Leaders

Dr. Lawrence N. Shulman Chief Medical Officer, Senior Vice-President for Medical Affairs, and Chief, Division of General Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

75 All Speakers and Session Leaders

Dr. Amy Sievers Fellow, Dana Farber Cancer Institute

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

76 All Speakers and Session Leaders

Dr. Robert Smith Director of Cancer Screening, American Cancer Society

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

77 All Speakers and Session Leaders

Dr. Tatiana Soldak Director of Programs, The Resource and Policy Exchange Tatiana Soldak, MD, is Director of Programs at the Resource & Policy Exchange (RPX), a US-based non- profit organization dedicated to equalizing standards of health care, information access, and participation in government around the world. Dr. Soldak has twelve years clinical experience in surgery in Belarus and twelve years of international development experience in public health. Dr. Soldak’s work at RPX focuses on the development of cancer control programs in the former Soviet republics.

She has extensive experience with public health policy analysis, including reviewing and analyzing public health laws; developing guidelines and regulations emphasizing health care equity (affordability, availability, accessibility); and advising health ministries with recommendations to strengthen and improve inadequate policies. Dr. Soldak has particular expertise in international policies and regulations within the pharmaceutical sector.

Dr. Soldak also works in program planning and management, including: situation analyses and needs assessments; program design and management; professional capacity building for local institutions; and monitoring and evaluation of international programs. She has special expertise developing awareness and patient advocacy for breast cancer, as well as managing medical and nutritional humanitarian responses. She is also involved in resource development for local non-profit organizations and associations.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

78 All Speakers and Session Leaders

Dr. Donna Spiegelman Professor of Epidemiologic Methods, Departments of Epidemiology and Biostatistics, Harvard School of Public Health Donna Spiegelman, ScD, is one of the few people in the world with a joint doctorate in Biostatistics and Epidemiology. As a result, she can freely speak the languages of both disciplines, and switch between the two cultures, playing the role of interlocutor for either. She is the statistician for the Nurses’ Health Study 2, the Health Professionals Follow-up Study, the Pooling Project of Prospective Studies of Diet and Cancer in Men and Women, the Harvard PEPFAR Dar es Salaam site, Trials of Vitamins in Dar es Salaam, and the multitude of projects spawned by these efforts. Her research is motivated by problems which arise in epidemiology and require biostatistical solutions. Dr. Spiegelman’s website is one of the most visited at the Harvard School of Public Health (HSPH), because it contains much user-friendly well-documented freeware implementing non-standard methods useful in epidemiologic research. Dr. Spiegelman’s most recent interest has been to work with various departments in an interdisciplinary effort to greatly increase global public health efforts at HSPH. In particular, Dr. Spiegelman is interested in developing, testing, and implementing preventive interventions to abate global cancer, diabetes and cardiovascular disease epidemics and offers her expertise in monitoring and evaluation to this end.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

79 All Speakers and Session Leaders

Dr. Yelena B. Wetherill Postdoctoral Research Fellow, Dana-Farber Cancer Institute

Founder, Women’s Health Exchange NGO Dr. Wetherill received her doctoral degree in molecular cancer biology from the University of Cincinnati College of Medicine, followed by postdoctoral training at Harvard Medical School/Dana-Farber Cancer Institute. In the last 4 years, Dr. Wetherill has been developing partnerships with Irkutsk Cancer Center and Women’s Union Angara, Russia, where most women are not informed about the benefits of screening mammography and breast cancer survival rates are only about 60%. The grassroots efforts initiated by Dr. Wetherill developed into an annual International Breast Health Symposium in Irkutsk, Russia. Dr. Wetherill is a founder and scientific advisor of Women’s Health Exchange NGO whose mission is to reduce stigma and empower people globally to seek early cancer screening by engaging medical, research and patient communities.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY

80 All Speakers and Session Leaders

Dr. Eric P. Winer Chief, Division of Women’s Cancers and Thompson Senior Investigator in Breast Cancer Research, Dana-Farber Cancer Institute Professor of Medicine, Harvard Medical School Eric P. Winer, MD, is Chief, Division of Women’s Cancers and the Thompson Senior Investigator in Breast Cancer Research at Dana-Farber Cancer Institute. He is also a Professor of Medicine at Harvard Medical School. Dr. Winer received his undergraduate and medical degrees from Yale University. After completing internal medicine and medical oncology training at Yale and Duke, he was on the faculty at Duke Medical Center for eight years before moving to Dana-Farber Cancer Institute in 1997. Dr. Winer is widely published, having authored over 200 articles, clinical communications, reviews, book chapters, and editorials. He serves on the editorial board for several peer-reviewed publications, including the Journal of Clinical Oncology and Breast Cancer Research and Treatment. Dr. Winer is co-chair of Cancer and Leukemia Group B (CALGB) Breast Committee. Dr. Winer is the current chair of the American Society of Clinical Oncology’s Cancer Communications Committee. He is the 2009 recipient of the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School. Dr. Winer is also the Chief Scientific Advisor and Chair of the Scientific Advisory Board for Susan G. Komen for the Cure.

BREAST CANCER IN THE DEVELOPING WORLD: MEETING THE UNFORSEEN CHALLENGE TO WOMEN, HEALTH AND EQUITY